Locations:
Search IconSearch
January 30, 2018/Neurosciences/Outcomes

Outcomes Snapshots: Bucking Trends in Stroke Mortality

Favorable rates may stem from focus on outcomes monitoring

17-NEU-4300-Russman-Stroke-Outcomes-650×450

After decades of decline, U.S. death rates from stroke have plateaued and even worsened in recent years, driven especially by trends in some areas of the country and among certain ethnic groups.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“Concerning national trends in recent years have highlighted the need for continued surveillance of stroke outcomes,” says Andrew Russman, DO, Medical Director of Cleveland Clinic’s Comprehensive Stroke Center.

Such surveillance has been the norm at Cleveland Clinic for years, and the latest outcomes findings reveal an encouraging bucking of these national trends. “Our data show that we are holding steady or doing better over time,” says Dr. Russman.

He’s referring to the bar graphs below showing annual in-hospital mortality from ischemic stroke (first graph) and intracerebral hemorrhage (second graph) at Cleveland Clinic over the years 2012 through 2016.

The graphs plot actual mortality at Cleveland Clinic against two benchmarks. The first is expected mortality, which is derived from the APR DRG system (see graph footnotes) and accounts for illness severity calculated from discharge billing codes and based on primary and secondary diagnoses, age and pre-existing conditions. The second benchmark is the standardized mortality ratio (SMR), which is the observed number of deaths divided by the number expected based on age- and sex-specific death rates in a standard population of stroke patients.

In every year, actual inpatient mortality for both stroke types was substantially lower than the expected rate — and in many cases approximately half the expected rate. Likewise, in every year the SMR was considerably less than 1.0 (see right vertical axis on each graph), indicating fewer deaths than expected.

Advertisement

Data on hospital length of stay were also collected for both stroke types, as detailed in the graphs below. In general, trends have been toward shorter stays over the past few years and mean stays have been shorter than expected based on APR DRG classifications.

Dr. Russman attributes the worsening national trends in stroke mortality to increasing obesity and the difficulty of controlling the associated risk factors for stroke, such as diabetes and hypertension. He says it’s uncertain why Cleveland Clinic’s stroke mortality rates have bucked these trends, but one contributing factor may be a highly collaborative approach. “We have an exemplary program for stroke care that brings together stroke neurologists, endovascular specialists, vascular neurosurgeons and neurointensivists in a single area to collaboratively manage patients as efficiently and effectively as possible,” he notes.

Another potential contributor is an openness to innovative approaches, as exemplified by Cleveland Clinic’s telemedicine-enabled mobile stroke treatment unit, the first of its kind in the country. This “emergency room on wheels” is summoned as an alternative to a standard ambulance when a 911 call is placed for someone experiencing stroke symptoms. The mobile unit contains blood testing capabilities, a CT scanner to assist in diagnosis and a telemedicine hookup to enable remote consultation with a stroke neurologist so that brain-saving measures can be started while the patient is en route to the hospital.

Advertisement

A final likely contributor is an abiding commitment to data-based continuous improvement. “We continually monitor our data and develop initiatives for process improvement,” Dr. Russman observes. “Detailed routine data collection like this can provide important insights for improving stroke care both at an institutional level and nationwide.”

These data and more are included in Cleveland Clinic’s comprehensive 2016 Neurological Institute Outcomes Book.

Advertisement

Related Articles

16-NEU-2800-Kubu-101058161-650×450

What Do Patients Want from DBS for Parkinson’s Disease?

New study advances understanding of patient-defined goals

photo of a man sleeping at a desk, with a podcast icon overlay
March 15, 2024/Neurosciences/Podcast

Diagnosis and Management of Idiopathic Hypersomnia (Podcast)

Testing options and therapies are expanding for this poorly understood sleep disorder

illustration of an alzheimer brain and a packet of sildenafil pills
March 11, 2024/Neurosciences/Research

Sildenafil as an Alzheimer’s Candidate Drug: Further Support From Insurance Database and Mechanistic Studies

Real-world claims data and tissue culture studies set the stage for randomized clinical testing

brain scan showing perimesencephalic subarachnoid hemorrhage

Study Supports Less-Strict Monitoring for Nonaneurysmal Perimesencephalic SAH Without Hydrocephalus

Digital subtraction angiography remains central to assessment of ‘benign’ PMSAH

illustrated brain with the letters "AI" on a computer circuit board

As AI Tools Emerge, Be Proactive and Engaged to Shape Their Development

Cleveland Clinic neuromuscular specialist shares insights on AI in his field and beyond

histology image of a gray matter lesion in a multiple sclerosis brain

Study Suggests Protective Role for Microglia at Borders of Gray Matter Lesions in Progressive MS

Findings challenge dogma that microglia are exclusively destructive regardless of location in brain

series of digital-looking brain icons with a podcast button overlay on top
March 1, 2024/Neurosciences/Podcast

Harnessing the Power of AI in Medicine (Podcast)

Neurology is especially well positioned for opportunities to enhance clinical care and medical training

illustration of a neuron affected by multiple sclerosis

Clinical Trials in Progressive MS: An Assessment of Advances and Remaining Challenges

New review distills insights from studies over the past decade

Ad